Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025
Tarsus Pharmaceuticals (NASDAQ: TARS) has announced it will host a live webcast on Tuesday, February 25, 2025, at 5:00 a.m. PT / 8:00 a.m. ET to present its fourth quarter and full-year 2024 financial results along with a corporate update. The webcast will be available for participants to access online, and a recorded version will be posted on the company's website shortly after the event, remaining accessible for approximately 90 days.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha annunciato che ospiterà un webcast dal vivo martedì 25 febbraio 2025, alle 5:00 PT / 8:00 ET per presentare i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 insieme a un aggiornamento aziendale. Il webcast sarà accessibile online per i partecipanti e una registrazione dell'evento sarà pubblicata sul sito web dell'azienda subito dopo l'evento, rimanendo accessibile per circa 90 giorni.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha anunciado que llevará a cabo un webcast en vivo el martes 25 de febrero de 2025, a las 5:00 a.m. PT / 8:00 a.m. ET para presentar sus resultados financieros del cuarto trimestre y del año completo 2024 junto con una actualización corporativa. El webcast estará disponible para que los participantes accedan en línea, y una versión grabada se publicará en el sitio web de la empresa poco después del evento, permaneciendo accesible durante aproximadamente 90 días.
타르수스 제약 (NASDAQ: TARS)는 2025년 2월 25일 화요일 오전 5시 PT / 오전 8시 ET에 2024년 4분기 및 연간 재무 결과와 기업 업데이트를 발표하기 위해 라이브 웹캐스트를 개최한다고 발표했습니다. 웹캐스트는 참가자들이 온라인으로 접근할 수 있으며, 이벤트 직후 회사 웹사이트에 녹화본이 게시되어 약 90일 동안 접근할 수 있습니다.
Tarsus Pharmaceuticals (NASDAQ: TARS) a annoncé qu'il organisera un webcast en direct le mardi 25 février 2025, à 5h00 PT / 8h00 ET pour présenter ses résultats financiers du quatrième trimestre et de l'année 2024 ainsi qu'une mise à jour de l'entreprise. Le webcast sera accessible en ligne pour les participants, et une version enregistrée sera publiée sur le site web de l'entreprise peu après l'événement, restant accessible pendant environ 90 jours.
Tarsus Pharmaceuticals (NASDAQ: TARS) hat angekündigt, dass am Dienstag, den 25. Februar 2025, um 5:00 Uhr PT / 8:00 Uhr ET ein Live-Webcast stattfinden wird, um die Finanzergebnisse des vierten Quartals und des gesamten Jahres 2024 sowie ein Unternehmensupdate zu präsentieren. Der Webcast wird für die Teilnehmer online zugänglich sein, und eine aufgezeichnete Version wird kurz nach der Veranstaltung auf der Website des Unternehmens veröffentlicht und bleibt etwa 90 Tage lang zugänglich.
- None.
- None.
IRVINE, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 5:00 a.m. PT / 8:00 a.m. ET on Tuesday, February 25, 2025, to report its fourth quarter and full-year 2024 financial results and provide a corporate update.
Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution,
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com
FAQ
When will Tarsus Pharmaceuticals (TARS) report Q4 and full-year 2024 earnings?
How can investors access the TARS Q4 2024 earnings webcast?
How long will the TARS Q4 2024 earnings webcast recording be available?
What will be covered in the Tarsus Pharmaceuticals (TARS) February 2025 webcast?
